The absorption of orally administered nafcillin sodium monohydrate buffered with calcium carbonate was studied in 10 healthy human volunteers. Dosages of 500 mg and 1 g were studied in fasting and nonfasting states. There was considerable individual variation in the absorption of nafcillin, although measurable serum concentrations were obtained in all subjects. With few exceptions, peak serum concentrations were reached faster and were more predictable in the fasting state than in the nonfasting state. In the majority of subjects, food interfered with nafcillin absorption. Measurable serum concentrations persisted for 4 h in almost all subjects, but there were no or negligible serum concentrations at 6 h. The mean serum concentrations obtained in the present study were higher than those reported in an earlier study.
Nafcillin, a semisynthetic penicillinase-resistant penicillin, is a valuable anti-staphylococcal antibiotic when it is given parenterally. However, it has been shown during clinical investigation of nafcillin that after oral administration of nafcillin, absorption was erratic in both fasting and nonfasting subjects, resulting in poor and unpredictable serum concentrations (7, 11) . Consequently, oral nafcillin therapy is not usually recommended (1, 5, 8) . There has been no recent study on oral nafcillin. The present investigation was designed to study the serum concentrations of nafcillin after oral ingestion of this antibiotic in a group of healthy human volunteers.
MATERIALS AND METHODS Antibiotic. The nafcillin preparation used in this study was in the form of film-coated tablets containing nafcillin sodium as the monohydrate, equivalent to 500 mg of nafcillin, buffered with calcium carbonate. Wyeth Laboratories, Inc., Philadelphia, Pa., kindly provided the entire supply needed for this study.
Volunteers. Eight male and two female healthy adults volunteered for the study. The research protocol was approved by the Committee on Human Research, University of Cincinnati College of Medicine. Written informed consent was obtained from all subjects.
Experimental designs. The study was divided into four phases, and all 10 volunteers participated in all four phases of the study. Each phase of the study was performed in weekly intervals.
During phase 1, all subjects received no food from midnight until noon of the day of the study. One tablet of nafcillin (500 mg) was ingested by each subject in the morning. Six milliliters of blood was withdrawn immediately prior to the administration of nafcillin and at 0.5, 1, 1.5, 2, 4, and 6 h after the drug was given.
Phase 2 was similar to phase 1, except that the subjects were allowed to eat breakfast and the nafcillin tablet was ingested within 1 h of breakfast.
In phase 3, the procedure of phase 1 was followed, except two tablets of nafcillin (1 g) were ingested instead of one.
Phase 4 was similar to phase 3, except that the subjects were allowed to eat breakfast and the study was performed within 1 h of breakfast.
Nafcillin assay. The blood was allowed to clot and the serum was separated. The serum samples were immediately frozen at -20°C until tested. In most instances, the samples were tested within 48 h of collection. Nafcillin assay was performed by the cylinder cup-plate agar diffusion method of Bennett et al., using Sarcina lutea as the test organism (2) .
Antibiotic standards were diluted in pooled human serum. Antibiotic standards as well as samples were assayed in triplicate, and the average measurements were used. All serum samples from each subject during the same phase of study were assayed in the same plate. RESULTS Results of the study are shown in Tables 1  and 2 . In the fasting subjects, measurable but markedly variable concentrations of nafcillin were obtained in all but one subject at 0.5 h. In all but one subject in each of the two fasting studies, peaked serum concentrations were attained at 1 h. One subject in each study attained peak serum concentrations at 1.5 h.
There was marked variation in the individual peak serum concentration among the subjects. At 6 h, no or negligible serum concentrations vailed. In all subjects, the peak serum concenwere found. tration was lower than that obtained in the In the nonfasting studies, the serum concen-fasting state. No or negligible serum antibiotic trations were even more unpredictable. In the activity was found at 6 h. 500-mg study, no antibiotic activity was found DISCUSSION in the 0.5-h specimens in seven subjects. However, in the remaining three subjects, peak se-
The results of this study confirm the previous rum concentrations were attained at 0.5 h. finding that there was considerable individual Peak serum concentrations were at 1.5 h in variation in the absorption of nafcillin administhree subjects, at 2 h in three subjects, and at 4 tered orally (7, 11) , although measurable serum h in the remaining subject. Again, the individ-concentrations were obtained in all subjects. ual peak serum concentration varied markedly Even in the same individual, the absorption among the subjects. The peak serum concentra-was not predictable. For example, subject no. 2 tion was the same in one, higher in three, and absorbed poorly in the 500-mg experiments, but lower in six subjects as compared with the val-had good absorption in the 1-g studies. With ues obtained in the fasting state. At 6 h, no or few exceptions, peaked serum concentrations negligible serum concentrations were found. In were reached faster and were more predictable the nonfasting 1-g study, peak serum concen-in the fasting state than in the nonfasting tration was attained at 1 h in seven, and in one state. In the majority of subjects, food intersubject each at 1.5, 2, and 4 h. Marked varia-fered with nafcillin absorption. (3, 4, 6, 10) , and authors of three of these reports commented specifically on these findings (4, 6, 10) . There is only one report on oral nafcillin in the literature comparable to the present study, using the same oral preparation (1 g ofnafcillin sodium monohydrate buffered with calcium carbonate) and the same antibiotic assay technique (cylinder cup-plate agar diffusion method using S. lutea as the test organism). Only mean values were given in that particular study, although in the summary and conclusion the authors commented that the serum activity varied widely in different individuals (7) . A comparison of the mean nafcillin serum concentrations from that and the present studies is given in Table 3 . In both studies, absorption of oral nafcillin was much better in fasting than nonfasting subjects. In both the fasting and nonfasting experiments, the mean serum concentrations from the present study were higher than those from the earlier study that was published in 1963. The significance ofthis finding is not known. It may be due to the mere fact that the results were from two different laboratories at two different times, or the formulation ofthe drug may not be exactly the same.
On the basis of the results of this and previous studies (7, 11) , it is concluded that the use of nafcillin orally is not warranted.
